» Articles » PMID: 20509719

Botanicals in Dermatology: an Evidence-based Review

Overview
Specialty Dermatology
Date 2010 Jun 1
PMID 20509719
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Botanical extracts and single compounds are increasingly used in cosmetics but also in over-the-counter drugs and food supplements. The focus of the present review is on controlled clinical trials with botanicals in the treatment of acne, inflammatory skin diseases, skin infections, UV-induced skin damage, skin cancer, alopecia, vitiligo, and wounds. Studies with botanical cosmetics and drugs are discussed, as well as studies with botanical food supplements. Experimental research on botanicals was considered to a limited extent when it seemed promising for clinical use in the near future. In acne therapy, Mahonia, tea tree oil, and Saccharomyces may have the potential to become standard treatments. Mahonia, Hypericum, Glycyrrhiza and some traditional Chinese medicines appear promising for atopic dermatitis. Some plant-derived substances like dithranol and methoxsalen (8-methoxypsoralen) [in combination with UVA] are already accepted as standard treatments in psoriasis; Mahonia and Capsicum (capsaicin) are the next candidates suggested by present evidence. Oral administration and topical application of antioxidant plant extracts (green and black tea, carotenoids, coffee, and many flavonoids from fruits and vegetables) can protect skin from UV-induced erythema, early aging, and irradiation-induced cancer. Hair loss and vitiligo are also traditional fields of application for botanicals. According to the number and quality of clinical trials with botanicals, the best evidence exists for the treatment of inflammatory skin diseases, i.e. atopic dermatitis and psoriasis. However, many more controlled clinical studies are needed to determine the efficacy and risks of plant-derived products in dermatology. Safety aspects, especially related to sensitization and photodermatitis, have to be taken into account. Therefore, clinicians should not only be informed of the beneficial effects but also the specific adverse effects of botanicals used for dermatologic disorders and cosmetic purposes.

Citing Articles

Preparation of -loaded electrospun nanofibers and evaluating its wound healing activity in a rat model of skin scar.

Almasi L, Arkan E, Farzaei M, Iranpanah A, Jalili C, Abbaszadeh F Front Pharmacol. 2025; 16:1533010.

PMID: 39959420 PMC: 11825791. DOI: 10.3389/fphar.2025.1533010.


: Phytochemical Profile and the Cosmeceutical and Dermatological Properties of Its Active Fraction from the Whole Plant.

Wu X, Wanyan M, Shi B, Huang R, Yang H, Wang X Molecules. 2025; 30(2).

PMID: 39860181 PMC: 11767586. DOI: 10.3390/molecules30020311.


Anti-Inflammatory Potential and Synergic Activities of (L.) L. Leaf-Derived Ointment Formulation in Combination with the Non-Steroidal Anti-Inflammatory Drug Diclofenac in Suppressing Atopic Dermatitis (AD).

Poyil M, Alsharif M, El-Bidawy M, Dayel S, Khan M, Omar Z Life (Basel). 2025; 15(1).

PMID: 39859974 PMC: 11766900. DOI: 10.3390/life15010035.


Exploring the Therapeutic Potential of Natural Compounds in Psoriasis and Their Inclusion in Nanotechnological Systems.

Burlec A, Hancianu M, Ivanescu B, Macovei I, Corciova A Antioxidants (Basel). 2024; 13(8).

PMID: 39199158 PMC: 11352172. DOI: 10.3390/antiox13080912.


Unlocking Therapeutic Potential: Comprehensive Extraction, Profiling, and Pharmacological Evaluation of Bioactive Compounds from (L.) Hassk. for Dermatological Applications.

Myo H, Liana D, Phanumartwiwath A Plants (Basel). 2024; 13(1).

PMID: 38202343 PMC: 10781016. DOI: 10.3390/plants13010033.